Back to Browse Journals » Open Access Bioinformatics » Volume 2

Computational methods for the identification of microRNA targets

Authors Yang Dai, Xiaofeng Zhou

Published Date May 2010 Volume 2010:2 Pages 29—39

DOI http://dx.doi.org/10.2147/OAB.S6902

Published 3 May 2010

Yang Dai1, Xiaofeng Zhou2

1Department of Bioengineering, Department of Computer Science, College of Engineering, 2Center for Molecular Biology of Oral Diseases, College of Dentistry, and Graduate College, UIC Cancer Center, University of Illinois at Chicago, Chicago, IL, USA

Abstract: MicroRNAs are pivotal regulators of development and cellular homeostasis. They act as post-transcriptional regulators, which control the stability and translation efficiency of their target mRNAs. The prediction of microRNA targets and detection of microRNA-mRNA regulatory modules (MRMs) are crucial components for understanding of microRNA functions. Numerous computational methods for microRNA target prediction have been developed. Computationally-predicted targets have been recently used in the integrative analysis of microRNA and mRNA expression analysis to identify microRNA targets and MRMs. In this article we review these recent developments in the integrative analysis methods. We also discuss the remaining challenges and our insights on future directions.

Keywords: microRNA target prediction, integrative analysis, microRNA regulatory mechanism, microRNA profiling, mRNA expression profiles

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Genome-wide mapping of chromatin state of mouse forelimbs

Eng D, Vogel WK, Flann NS, Gross MK, Kioussi C

Open Access Bioinformatics 2014, 6:1-11

Published Date: 10 September 2014

Diabetic and non-diabetic human cornea and tear γ-glutamyl transpeptidase activity

Burnham JM, Sakhalkar M, Langford MP, Liang C, Redens TB, Jain SK

Clinical Ophthalmology 2013, 7:99-107

Published Date: 10 January 2013

Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages

Murata M, Narahara S, Umezaki K, Toita R, Tabata S, Piao JS, Abe K, Kang JH, Ohuchida K, Cui L, Hashizume M

International Journal of Nanomedicine 2012, 7:4353-4362

Published Date: 9 August 2012

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I

Neuropsychiatric Disease and Treatment 2012, 8:85-93

Published Date: 9 February 2012

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease

Stricker RB, DeLong AK, Green CL, Savely VR, Chamallas SN, Johnson L

International Journal of General Medicine 2011, 4:639-646

Published Date: 6 September 2011

Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection

RM Mukherjee, P Balkumar Reddy, Jyothi Arava, et al

Hepatic Medicine: Evidence and Research 2010, 2:157-162

Published Date: 16 November 2010

Erratum

RA Kurt, K Gündüz

Clinical Ophthalmology 2010, 4:981-982

Published Date: 6 September 2010

Clinical profile of hypertension at a University Teaching Hospital in Nigeria

Arthur C Onwuchekwa, Sunday Chinenye

Vascular Health and Risk Management 2010, 6:511-516

Published Date: 1 July 2010

Characterizing blood microparticles: Technical aspects and challenges

Arun S Shet

Vascular Health and Risk Management 2008, 4:769-774

Published Date: 4 September 2008

Fifty years chlorpromazine: a historical perspective

Thomas A Ban

Neuropsychiatric Disease and Treatment 2007, 3:495-500

Published Date: 8 October 2007